University of Minnesota. Driven to Discover.
Merck's rVSV-ZEBOV is the only vaccine that will be used during the ever-growing outbreak in North Kivu and Ituri provinces.
The new cases raise the number of infected healthcare workers to 132, 68% of whom are nurses.
Antibiotic prescribing guided by C-reactive protein testing resulted in a lower rate of those drugs for COPD exacerbations in Britain.
The agency says prompt reporting is key to help figure out the cause of the mysterious limb-weakening condition.
The idea is to delink profit from the volume sold, pay for antibiotics based on their public health value, and encourage development of new antibiotics.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.